Valeurs

Valeurs

Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices.

Show advanced options

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Nom	Code	Analysis date	Cours de clôture	+/- %
S&W Seed	SANW	22. nov 2024	6.57	+26.35
SAB Biotherapeutics	SABS	22. nov 2024	3.13	+1.95
Saba Capital	BRW	22. nov 2024	7.61	+0.26
Saba Capital Income & Opportunities Fund II	SABA	22. nov 2024	8.69	-0.11
Sabine Royalty Trust Unit	SBR	22. nov 2024	63.07	+0.62
Sable Offshore	SOC	22. nov 2024	24.08	+4.60
Sabra Health Care REIT	SBRA	22. nov 2024	18.41	+0.33
Sabre	SABR	22. nov 2024	3.73	+1.63
Sachem Capital	SACH	22. nov 2024	1.59	0.00
Sachem Capital A Pref	SACH-A	22. nov 2024	19.14	-2.94
Sacks Parente Golf	SPGC	22. nov 2024	1.59	-1.13
Sadot Group	SDOT	22. nov 2024	3.36	-4.82
Safe & Green Holdings	SGBX	22. nov 2024	0.52	+1.75
Safe And Green Development	SGD	22. nov 2024	1.90	+6.15
Safe Bulkers	SB	22. nov 2024	4.17	+1.21
Safe Bulkers Pref C	SB-C	22. nov 2024	25.51	0.00
Safe Bulkers Pref D	SB-D	22. nov 2024	25.95	+0.73
Safe Pro Group	SPAI	22. nov 2024	4.57	0.00
Safehold	SAFE	22. nov 2024	20.81	+1.71
Safety Insurance Group	SAFT	22. nov 2024	84.86	+0.11
Safety Shot	SHOT	22. nov 2024	0.83	-5.11
SAG Holdings Limited - Ordinary Shares	SAG	22. nov 2024	2.74	0.00
Saga Communications A	SGA	22. nov 2024	13.19	+4.52
Sage Therapeutics	SAGE	22. nov 2024	5.17	+6.60
Sagimet Biosciences	SGMT	22. nov 2024	4.76	+5.78
SAI.TECH Global	SAI	22. nov 2024	0.75	0.00
Saia	SAIA	22. nov 2024	541.69	-1.37
SAIHEAT A	SAIH	22. nov 2024	1.11	0.00
Salarius Pharmaceuticals	SLRX	22. nov 2024	1.37	-6.16
Salesforce	CRM	22. nov 2024	342.02	+1.86

Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.